Aug 5 (Reuters) – Mironid: * MIRONID RAISES $46 MILLION IN SERIES B FINANCING TO ADVANCE CLINICAL DEVELOPMENT OF ITS TREATMENT FOR RARE KIDNEY DISEASE Source text: Further company coverage: [ ]
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)